Search Result

Results for "

Gomisin L-2

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Cytotoxin (1) Amino Acid Derivatives (2) AMPK (1) Amyloid-β (2) Apoptosis (2) Autophagy (2) Biochemical Assay Reagents (3) Calcium Channel (1) Cytochrome P450 (2) DNA/RNA Synthesis (1) Endogenous Metabolite (26) GABA Receptor (2) HBV (1) Histone Demethylase (4) HIV (5) iGluR (1) Interleukin Related (1) Isotope-Labeled Compounds (8) LAG-3 (1) Mitochondrial Metabolism (4) NF-κB (1) Nuclear Factor of activated T Cells (NFAT) (1) Nucleoside Antimetabolite/Analog (1) PD-1/PD-L1 (12) Phosphodiesterase (PDE) (1) Reactive Oxygen Species (2) Small Interfering RNA (siRNA) (44) Telomerase (3) Thymidylate Synthase (1) TNF Receptor (1) UGT (1)
By Research Areas:	Cancer (33) Cardiovascular Disease (1) Infection (5) Inflammation/Immunology (11) Metabolic Disease (24) Neurological Disease (22)
Oligonucleotides:	Nucleosides and their Analogs (1) Pre-designed siRNA Sets (44) siRNAs (44)

123

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N5001

Euphorbia Factor L2	Apoptosis	Cancer
Euphorbia factor L2, a lathyrane diterpenoid isolated from caper euphorbia seed (the seeds of Euphorbia lathyris L.), has been traditionally applied to treat cancer. Euphorbia factor L2 shows potent cytotoxicity and induces apoptosis via a mitochondrial pathway .

HY-N1529

Gomisin M1 (±)-Gomisin M1	HIV	Infection
Gomisin M1 ((±)-Gomisin M1) is a potent anti-HIV agent with an EC₅₀ of <0.65 μM .

HY-N3963

Gomisin M2 (+)-Gomisin M2	HIV	Infection Neurological Disease Inflammation/Immunology Cancer
Gomisin M2 ((+)-Gomisin M2) is a lignan isolated from the fruits of Schisandra rubriflora with anti-HIV activity (EC₅₀ of 2.4 μM). Gomisin M2 exhibits anti-cancer and anti-allergic activities and has the potential for Alzheimer’s disease research ^[2].

HY-N6866

Gomisin N	Apoptosis	Neurological Disease Inflammation/Immunology Cancer
Gomisin N, isolated from Schisandra chinensis. Gomisin N has the potential for use in the treatment of allergy. Gomisin N is an anti-cancer agent candidate capable of inhibiting the proliferation and inducing the apoptosis in cancer ^[2] .

HY-N2413

Gomisin D	Others	Metabolic Disease
Gomisin D, a lignan compound isolated from Fructus Schisandra, is a potential antidiabetic and anti-Alzheimer’s agent. Gomisin D inhibits UDP-Glucuronosyltransferases activity and scavenges ABTS(+) radicals. Gomisin D is used as a quality marker of Shengmai San and shenqi Jiangtang Granule .

HY-N8400

Roridin L2	Endogenous Metabolite	Others
Roridin L2, a fungal metabolite, is a biosynthetic precursor of Satratoxin G. Roridin L2 possesses little in vitro or in vivo toxic activity .

HY-N7485

Gomisin K1 (-)-Gomisin K1	Others	Cancer
Gomisin K1 ((-)-Gomisin K1) is a lignan that exhibits anti-cancer activity. Gomisin K1 inhibits HeLa cell growth, with an IC₅₀ of 5.46 μM .

HY-N0858R

Gomisin G (Standard)	HIV	Infection
Gomisin G (Standard) is the analytical standard of Gomisin G. This product is intended for research and analytical applications.

HY-N8158

Gomisin S	Others	Others
Gomisin S is a dibenzocyclooctadiene lignan .

HY-N8159

Gomisin U	Others	Others
Gomisin U is a lignan compound .

HY-N2235

Gomisin O	Others	Inflammation/Immunology
Gomisin O is isolated from the fruits of Schizandra chinensis .

HY-N0385

Gomisin J 3 Publications Verification	AMPK Calcium Channel	Cardiovascular Disease Metabolic Disease
Gomisin J is a small molecular weight lignan found in Schisandra chinensis and has been demonstrated to have vasodilatory activity . Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and *Ca ²⁺/calmodulin-dependent* protein kinase II and inhibition of fetuin-A** in HepG2 cells. gomisin J has potential benefits in treating nonalcoholic fatty liver disease ^[2].

HY-N2246

Gomisin H	Others	Inflammation/Immunology
Gomisin H is a dibenzocyclooctadiene lignan isolated from the fruits of Schizandra chinensis BAILL .

HY-N7958

Gomisin F	Others	Others
Gomisin F is a Lignans product that can be isolated from the seeds of Schisandra chinensis (Turcz.) Baill. .

HY-N2265

*Angeloyl-(+)-gomisin* K3**	Others	Others
Angeloyl-(+)-gomisin K3 is a dibenzocyclooctane lignan .

HY-N7310

Gomisin E	Nuclear Factor of activated T Cells (NFAT)	Others
Gomisin E, a dibenzocyclooctadiene lignan isolated from the fruits of Schizandra chinensis, inhibits NFAT transcription with an IC₅₀ of 4.73 μM ^[2].

HY-N0858

Gomisin G 1 Publications Verification	HIV	Infection
Gomisin G is an ethanolic extract of the stems of Kadsura interior; exhibits potent anti-HIV activity with EC50 and therapeutic index (TI) values of 0.006 microgram/mL and 300, respectively.

HY-N7825

Gomisin L1	Others	Cancer
Gomisin L1 is a lignan, shows inhibitory effect on cell viability of A2780 and Ishikawa cells, with IC₅₀s of 39.06 μM and 74.16 μM, respectively .

HY-N0695

Schisantherin B Gomisin-B; Wuweizi ester-B; Schisantherin-B	Amyloid-β	Inflammation/Immunology
Schisantherin B (Gomisin-B; Wuweizi ester-B; Schisantherin-B) is a natural product.

HY-128358

MR-L2	Phosphodiesterase (PDE)	Neurological Disease
MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4), activates representative PDE4 long-isoform variants (PDE4A4, PDE4B1, PDE4C3, PDE4D5). MR-L2 suppresses PGE2-induced MDCK cell cyst formation with an EC₅₀ of 1.2 µM .

HY-N0692

Schisandrol B 2 Publications Verification Gomisin-A; TJN-101; Wuweizi alcohol-B	Reactive Oxygen Species Cytochrome P450 Autophagy	Cancer
Schisandrol B (Gomisin-A) is a major active constituent of Schisandra chinensis with hepato-protective effects. Schisandrol B inhibits reactive oxygen species (ROS) production. Schisandrol B inhibits the activity of P-glycoprotein and CYP3A and also has anti-inflammatory, anti-diabetic and antioxidant activities ^[2] .

HY-P9972

Spartalizumab PDR001	PD-1/PD-L1	Cancer
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .

HY-P99610

Ezabenlimab BI-754091	PD-1/PD-L1	Cancer
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant K_d value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and *PD-L2*. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .

HY-P99639

Geptanolimab APL-501; CBT-501; GB-226	PD-1/PD-L1	Cancer
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .

HY-P99345

Dostarlimab TSR-042	PD-1/PD-L1	Cancer
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC₅₀s of 1.8 and 1.5 nM, respectively .

HY-101093

CA-170 1 Publications Verification	PD-1/PD-L1	Inflammation/Immunology Cancer
CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1. CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes ^[2].

HY-P9902A

Pembrolizumab (anti-PD-1) 2 Publications Verification MK-3475 (anti-PD-1); Lambrolizumab (anti-PD-1)	PD-1/PD-L1	Cancer
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 ^[2].

HY-N0859

Schisanhenol Schizanhenol; Gomisin-K3	UGT	Cancer
Schisanhenol is a natural compound solated from Schisandra rubriflora; UGT2B7 UDP-glucuronosyltransferases inhibitor.

HY-P1812

AUNP-12 3 Publications Verification NP-12	PD-1/PD-L1	Cancer
AUNP-12 (NP-12) is a peptide antagonist of the PD-1 signaling pathway, displays equipotent antagonism toward PD-L1 and PD-L2 in rescue of lymphocyte proliferation and effector functions. AUNP-12 exhibits immune activation, excellent antitumor activity, and potential for better management of immune-related adverse events (irAEs) .

HY-P1812A

AUNP-12 TFA 3 Publications Verification NP-12 TFA	PD-1/PD-L1	Cancer
AUNP-12 TFA (NP-12 TFA) is a peptide antagonist of the PD-1 signaling pathway, displays equipotent antagonism toward PD-L1 and PD-L2 in rescue of lymphocyte proliferation and effector functions. AUNP-12 TFA exhibits immune activation, excellent antitumor activity, and potential for better management of immune-related adverse events (irAEs) .

HY-N0695R

Schisantherin B (Standard)	Amyloid-β	Inflammation/Immunology
Schisantherin B (Standard) is the analytical standard of Schisantherin B. This product is intended for research and analytical applications. Schisantherin B (Gomisin-B; Wuweizi ester-B; Schisantherin-B) is a natural product.

HY-P99052

Tislelizumab 2 Publications Verification	PD-1/PD-L1	Inflammation/Immunology Cancer
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma ^[2] .

HY-P99109

Zimberelimab GLS-010; AB-122; WBP-3055	PD-1/PD-L1	Cancer
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC₅₀ of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC₅₀ values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma ^[2].

HY-P99499

Cetrelimab JNJ 63723283; JNJ 3283	PD-1/PD-L1 Interleukin Related TNF Receptor	Cancer
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (K_d=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and *PD-L2* (IC₅₀s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, *IL-2, TNF-α* level and inhibits tumor growth in vivo .

HY-P99048

Sintilimab IBI308	PD-1/PD-L1	Inflammation/Immunology Cancer
Sintilimab (IBI308) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a K_D value of 74 pM. Sintilimab blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer ^[2] .

HY-N0694

Schisantherin A 1 Publications Verification Gomisin-C; Schizantherin-A; Wuweizi ester-A	NF-κB	Inflammation/Immunology
Schisantherin A is a dibenzocyclooctadiene lignan. Schisantherin A inhibits p65-NF-κB translocation into the nucleus by IκBα degradation.

HY-P99573

Tebotelimab MGD-013	LAG-3	Inflammation/Immunology Cancer
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC₅₀s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity ^[2] .

HY-16638

CB 3717 PDDF	Thymidylate Synthase	Metabolic Disease
CB 3717 is a potent inhibitor of human thymidylate synthetase, competitively binding with 5,10-methylenetetrahydrofolate (Ki = 4.9 X 10(-9) M). It also competitively inhibits human dihydrofolate reductase with dihydrofolate (Ki = 2.3 X 10(-8) M). In WI-L2 human lymphoblastoid cells, CB 3717 treatment led to a significant decrease in cellular dTTP levels and a notable increase in dUMP levels, indicating a disruption in nucleotide metabolism. The growth-inhibitory effect of CB 3717 was reversed by thymidine supplementation, demonstrating that thymidylate synthetase became rate-limiting in the presence of this compound. Delayed thymidine supplementation beyond 8 hours resulted in severe cytotoxicity, underscoring the critical timing of nucleotide rescue strategies in CB 3717-treated cells .

HY-128736

L-2-Phosphoglyceric acid	Endogenous Metabolite	Metabolic Disease
L-2-Phosphoglyceric acid is an endogenous metabolite .

HY-128736C

L-2-Phosphoglyceric acid sodium hydrate	Endogenous Metabolite	Metabolic Disease
L-2-Phosphoglyceric acid sodium hydrate is an endogenous metabolite .

HY-N0692R

Schisandrol B (Standard)	Reactive Oxygen Species Cytochrome P450 Autophagy	Cancer
Schisandrol B (Standard) is the analytical standard of Schisandrol B. This product is intended for research and analytical applications. Schisandrol B (Gomisin-A) is a major active constituent of Schisandra chinensis with hepato-protective effects. Schisandrol B inhibits reactive oxygen species (ROS) production. Schisandrol B inhibits the activity of P-glycoprotein and CYP3A and also has anti-inflammatory, anti-diabetic and antioxidant activities ^[2] .

HY-148171

L-2'-Fd4C	HIV HBV DNA/RNA Synthesis Nucleoside Antimetabolite/Analog	Infection
L-2'-Fd4C, is an l-nucleoside analogue. L-2'-Fd4C has anti-human immunodeficiency virus (HIV) and anti-hepatitis B virus (HBV) activity .

HY-N3834

*Epipterosin L 2'-O-glucoside*	Others	Others
Epipterosin L 2'-O-glucoside is a Sesquiterpenoids product that can be isolated from the rhizomes of Cibotium barometz (L.) J.Sm. .

HY-101414

L-DABA L-2,4-Diaminobutyric acid	GABA Receptor Endogenous Metabolite	Neurological Disease Cancer
L-DABA (L-2,4-Diaminobutyric acid) is a week GABA transaminase inhibitor with an IC₅₀ of larger than 500 μM; exhibits antitumor activity in vivo and in vitro.

HY-113039

L-2-Hydroxyglutaric acid (S)-2-Hydroxyglutaric acid	Histone Demethylase Mitochondrial Metabolism Endogenous Metabolite	Cancer
L-2-Hydroxyglutaric acid is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with K_m and K_i of 2.52 mM and 11.13 mM, respectively ^[2].

HY-148200

L2H2-6OTD	ADC Cytotoxin Telomerase	Cancer
L2H2-6OTD, containing one to four G-quadruplex binding loops, is a telomeric inhibitor analogue. l2H2-6OTD has telomerase inhibitory activity with an IC₅₀ value of 15 nM .

HY-148200A

L2H2-6OTD diformic	Telomerase	Cancer
L2H2-6OTD acetate contains one to four G-quadruplex binding loops and is a telomere inhibitor analog. L2H2-6OTD acetate has telomerase inhibitory activity with an IC₅₀ value of 15 nM .

HY-W015114

L-2-Hydroxyglutaric acid disodium (S)-2-Hydroxyglutaric acid disodium	Histone Demethylase Mitochondrial Metabolism Endogenous Metabolite	Cancer
L-2-Hydroxyglutaric acid disodium is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid disodium can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with K_m and K_i of 2.52 mM and 11.13 mM, respectively ^[2].

HY-101414A

L-DABA hydrobromide L-2,4-Diaminobutyric acid hydrobromide	Endogenous Metabolite GABA Receptor	Neurological Disease Cancer
L-DABA (L-2,4-Diaminobutyric acid) hydrobromide is a week GABA transaminase inhibitor with an IC₅₀ of larger than 500 μM; exhibits antitumor activity in vivo and in vitro.

HY-48517

L2H2-6OTD intermediate-1	Others	Cancer
L2H2-6OTD intermediate-1 is an intermediate for the synthesis of L2H2-6OTD (HY-148200) and can be used for ADC preparation. L2H2-6OTD, a telomestatin analog with telomerase inhibitory activity (IC₅₀: 15 nM) .

Cat. No.	Product Name	Type

HY-W088147

*Z-L-2-Nal-OH* Z-2-Nal-OH	Biochemical Assay Reagents
Z-L-2-Nal-OH (Z-2-Nal-OH) is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-W010018

(S)-L-DABA dihydrochloride (S)-L-2,4-Diaminobutyric acid dihydrochloride	Biochemical Assay Reagents
(S)-L-DABA dihydrochloride is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W145592

1L-epi-2-Inosose 2L-2,3,4,6/5-Pentahydroxycyclohexanone	Biochemical Assay Reagents
1L-epi-2-Inosose is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

Cat. No.	Product Name	Target	Research Area

HY-34611

*Boc-L-2,4-Diaminobutyric acid* N-Boc-L-2,4-diaminobutyric acid; Boc-Dab-OH	Peptides	Neurological Disease Cancer
Boc-L-2,4-Diaminobutyric acid is a derivative of L-2,4-Diaminobutyric acid (HY-101414) ^[1.

HY-P1812

AUNP-12 3 Publications Verification NP-12	PD-1/PD-L1	Cancer
AUNP-12 (NP-12) is a peptide antagonist of the PD-1 signaling pathway, displays equipotent antagonism toward PD-L1 and PD-L2 in rescue of lymphocyte proliferation and effector functions. AUNP-12 exhibits immune activation, excellent antitumor activity, and potential for better management of immune-related adverse events (irAEs) .

HY-P1812A

AUNP-12 TFA 3 Publications Verification NP-12 TFA	PD-1/PD-L1	Cancer
AUNP-12 TFA (NP-12 TFA) is a peptide antagonist of the PD-1 signaling pathway, displays equipotent antagonism toward PD-L1 and PD-L2 in rescue of lymphocyte proliferation and effector functions. AUNP-12 TFA exhibits immune activation, excellent antitumor activity, and potential for better management of immune-related adverse events (irAEs) .

HY-79415

4-Methyl-L-leucine L-Leucine, 4-methyl- (9CI); L-2-Amino-4,4-dimethylpentanoic acid; L-γ-Methylleucine	Amino Acid Derivatives	Others
4-Methyl-L-leucine is a Glycine (HY-Y0966) derivative .

HY-79046

*Boc-L-2-aminobutanoic acid* Butanoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, (S)-; Butyric acid, 2-(carboxyamino)-, N-tert-butyl ester, L- (8CI); (2S)-2-(tert-Butoxycarbonylamino)butanoic acid; (2S)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]butanoic acid	Amino Acid Derivatives	Others
Boc-L-2-aminobutanoic acid is an alanine derivative .

Cat. No.	Product Name	Target	Research Area

HY-P9972

Spartalizumab PDR001	PD-1/PD-L1	Cancer
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .

HY-P99763

Ociperlimab BGB-A1217	Inhibitory Antibodies	Cancer
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (K_D = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer ^[2].

HY-P99610

Ezabenlimab BI-754091	PD-1/PD-L1	Cancer
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant K_d value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and *PD-L2*. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .

HY-P99639

Geptanolimab APL-501; CBT-501; GB-226	PD-1/PD-L1	Cancer
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .

HY-P99345

Dostarlimab TSR-042	PD-1/PD-L1	Cancer
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC₅₀s of 1.8 and 1.5 nM, respectively .

HY-P9902A

Pembrolizumab (anti-PD-1) 2 Publications Verification MK-3475 (anti-PD-1); Lambrolizumab (anti-PD-1)	PD-1/PD-L1	Cancer
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1 ^[2].

HY-P99052

Tislelizumab 2 Publications Verification	PD-1/PD-L1	Inflammation/Immunology Cancer
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma ^[2] .

HY-P99109

Zimberelimab GLS-010; AB-122; WBP-3055	PD-1/PD-L1	Cancer
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC₅₀ of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC₅₀ values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma ^[2].

HY-P99499

Cetrelimab JNJ 63723283; JNJ 3283	PD-1/PD-L1 Interleukin Related TNF Receptor	Cancer
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (K_d=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and *PD-L2* (IC₅₀s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, *IL-2, TNF-α* level and inhibits tumor growth in vivo .

HY-P990170

Anti-Mouse PD-L2/B7-DC Antibody (TY25)	Inhibitory Antibodies	Others
Anti-Mouse PD-L2/B7-DC Antibody (TY25) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse PD-L2/B7-DC.

HY-P99048

Sintilimab IBI308	PD-1/PD-L1	Inflammation/Immunology Cancer
Sintilimab (IBI308) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a K_D value of 74 pM. Sintilimab blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer ^[2] .

HY-P99573

Tebotelimab MGD-013	LAG-3	Inflammation/Immunology Cancer
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC₅₀s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity ^[2] .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N5001

Euphorbia Factor L2	Classification of Application Fields Terpenoids Gramineae Source classification Diterpenoids Leptochloa chinensis (Linn.) Nees Plants Disease Research Fields Cancer	Apoptosis
Euphorbia factor L2, a lathyrane diterpenoid isolated from caper euphorbia seed (the seeds of Euphorbia lathyris L.), has been traditionally applied to treat cancer. Euphorbia factor L2 shows potent cytotoxicity and induces apoptosis via a mitochondrial pathway .

HY-N1529

Gomisin M1 (±)-Gomisin M1	Structural Classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	HIV
Gomisin M1 ((±)-Gomisin M1) is a potent anti-HIV agent with an EC₅₀ of <0.65 μM .

HY-N3963

Gomisin M2 (+)-Gomisin M2	Classification of Application Fields Neurological Disease Source classification Lignans Plants Infection Monophenols Phenols Phenylpropanoids Schisandraceae Disease Research Fields Inflammation/Immunology Schisandra chinensis (Turcz.) Baill.	HIV
Gomisin M2 ((+)-Gomisin M2) is a lignan isolated from the fruits of Schisandra rubriflora with anti-HIV activity (EC₅₀ of 2.4 μM). Gomisin M2 exhibits anti-cancer and anti-allergic activities and has the potential for Alzheimer’s disease research ^[2].

HY-N6866

Gomisin N	Structural Classification Neurological Disease Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Inflammation/Immunology Disease Research Fields Schisandra chinensis (Turcz.) Baill. Cancer	Apoptosis
Gomisin N, isolated from Schisandra chinensis. Gomisin N has the potential for use in the treatment of allergy. Gomisin N is an anti-cancer agent candidate capable of inhibiting the proliferation and inducing the apoptosis in cancer ^[2] .

HY-N2413

Gomisin D	Classification of Application Fields Source classification Lignans Metabolic Disease Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill.	Others
Gomisin D, a lignan compound isolated from Fructus Schisandra, is a potential antidiabetic and anti-Alzheimer’s agent. Gomisin D inhibits UDP-Glucuronosyltransferases activity and scavenges ABTS(+) radicals. Gomisin D is used as a quality marker of Shengmai San and shenqi Jiangtang Granule .

HY-N8400

Roridin L2	Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Source classification Other Diseases Disease Research Fields	Endogenous Metabolite
Roridin L2, a fungal metabolite, is a biosynthetic precursor of Satratoxin G. Roridin L2 possesses little in vitro or in vivo toxic activity .

HY-N7485

Gomisin K1 (-)-Gomisin K1	Structural Classification Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	Others
Gomisin K1 ((-)-Gomisin K1) is a lignan that exhibits anti-cancer activity. Gomisin K1 inhibits HeLa cell growth, with an IC₅₀ of 5.46 μM .

HY-N0858R

Gomisin G (Standard)	Structural Classification Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	HIV
Gomisin G (Standard) is the analytical standard of Gomisin G. This product is intended for research and analytical applications.

HY-N8158

Gomisin S	Monophenols Classification of Application Fields Source classification Lignans Other Diseases Phenols Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill.	Others
Gomisin S is a dibenzocyclooctadiene lignan .

HY-N8159

Gomisin U	Schisandra sphenanthera Rehd. et Wils Monophenols Classification of Application Fields Source classification Lignans Other Diseases Phenols Phenylpropanoids Plants Schisandraceae Disease Research Fields	Others
Gomisin U is a lignan compound .

HY-N2235

Gomisin O	Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Disease Research Fields Inflammation/Immunology Schisandra chinensis (Turcz.) Baill.	Others
Gomisin O is isolated from the fruits of Schizandra chinensis .

HY-N0385

Gomisin J 3 Publications Verification	Cardiovascular Disease Monophenols Classification of Application Fields Source classification Lignans Phenols Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill.	AMPK Calcium Channel
Gomisin J is a small molecular weight lignan found in Schisandra chinensis and has been demonstrated to have vasodilatory activity . Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and *Ca ²⁺/calmodulin-dependent* protein kinase II and inhibition of fetuin-A** in HepG2 cells. gomisin J has potential benefits in treating nonalcoholic fatty liver disease ^[2].

HY-N2246

Gomisin H	Structural Classification Monophenols Classification of Application Fields Source classification Lignans Phenols Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill. Inflammation/Immunology Disease Research Fields	Others
Gomisin H is a dibenzocyclooctadiene lignan isolated from the fruits of Schizandra chinensis BAILL .

HY-N7958

Gomisin F	Structural Classification Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	Others
Gomisin F is a Lignans product that can be isolated from the seeds of Schisandra chinensis (Turcz.) Baill. .

HY-N2265

*Angeloyl-(+)-gomisin* K3**	Structural Classification Natural Products Classification of Application Fields Source classification Other Diseases Schisandra bicolor Cheng Plants Schisandraceae Disease Research Fields	Others
Angeloyl-(+)-gomisin K3 is a dibenzocyclooctane lignan .

HY-N7310

Gomisin E	Structural Classification Classification of Application Fields Source classification Lignans Other Diseases Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill.	Nuclear Factor of activated T Cells (NFAT)
Gomisin E, a dibenzocyclooctadiene lignan isolated from the fruits of Schizandra chinensis, inhibits NFAT transcription with an IC₅₀ of 4.73 μM ^[2].

HY-N0858

Gomisin G 1 Publications Verification	Infection Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill.	HIV
Gomisin G is an ethanolic extract of the stems of Kadsura interior; exhibits potent anti-HIV activity with EC50 and therapeutic index (TI) values of 0.006 microgram/mL and 300, respectively.

HY-N7825

Gomisin L1	Triterpenes Structural Classification Terpenoids Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	Others
Gomisin L1 is a lignan, shows inhibitory effect on cell viability of A2780 and Ishikawa cells, with IC₅₀s of 39.06 μM and 74.16 μM, respectively .

HY-N0695

Schisantherin B Gomisin-B; Wuweizi ester-B; Schisantherin-B	Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Disease Research Fields Inflammation/Immunology Schisandra chinensis (Turcz.) Baill.	Amyloid-β
Schisantherin B (Gomisin-B; Wuweizi ester-B; Schisantherin-B) is a natural product.

HY-N0692

Schisandrol B 2 Publications Verification Gomisin-A; TJN-101; Wuweizi alcohol-B	Structural Classification Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill. Disease Research Fields Cancer	Reactive Oxygen Species Cytochrome P450 Autophagy
Schisandrol B (Gomisin-A) is a major active constituent of Schisandra chinensis with hepato-protective effects. Schisandrol B inhibits reactive oxygen species (ROS) production. Schisandrol B inhibits the activity of P-glycoprotein and CYP3A and also has anti-inflammatory, anti-diabetic and antioxidant activities ^[2] .

HY-P9972

Spartalizumab PDR001	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC) .

HY-P99763

Ociperlimab BGB-A1217	Classification of Application Fields Disease Research Fields Cancer	Others
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (K_D = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer ^[2].

HY-P99610

Ezabenlimab BI-754091	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant K_d value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and *PD-L2*. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo .

HY-P99639

Geptanolimab APL-501; CBT-501; GB-226	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer .

HY-P99345

Dostarlimab TSR-042	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC₅₀s of 1.8 and 1.5 nM, respectively .

HY-N0859

Schisanhenol Schizanhenol; Gomisin-K3	Structural Classification Monophenols Classification of Application Fields Source classification Lignans Phenols Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill. Cancer	UGT
Schisanhenol is a natural compound solated from Schisandra rubriflora; UGT2B7 UDP-glucuronosyltransferases inhibitor.

HY-N0695R

Schisantherin B (Standard)	Structural Classification Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	Amyloid-β
Schisantherin B (Standard) is the analytical standard of Schisantherin B. This product is intended for research and analytical applications. Schisantherin B (Gomisin-B; Wuweizi ester-B; Schisantherin-B) is a natural product.

HY-P99052

Tislelizumab 2 Publications Verification	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Tislelizumab is a monoclonal antibody that specifically binds to programmed cell death receptor 1 (PD-1), blocking its interaction with programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2). Tislelizumab can reactivate immune cells such as T lymphocytes and enhance anti-tumor activity. Tislelizumab can be used for the research of a variety of tumors including typical Hodgkin's lymphoma, urothelial carcinoma, non-small cell lung cancer and hepatocellular carcinoma ^[2] .

HY-P99109

Zimberelimab GLS-010; AB-122; WBP-3055	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Zimberelimab (GLS-010) is a fully human IgG4 anti-PD-1 monoclonal antibody with an EC₅₀ of 210 pM for human PD-1. Zimberelimab effectively blocks the binding of PD-L1 and PD-L2 to cell-surface PD-1 in CHO-S cells, with IC₅₀ values of 580 pM and 670 pM, respectively. Zimberelimab shows antitumor activities, and can be used for various cancers research, including cervical cancer, non-small cell lung cancer and classical Hodgkin’s lymphoma ^[2].

HY-P99499

Cetrelimab JNJ 63723283; JNJ 3283	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1 Interleukin Related TNF Receptor
Cetrelimab (JNJ 63723283; JNJ 3283) is a human IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (K_d=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and *PD-L2* (IC₅₀s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab stimulates peripheral T cells, increases IFN-γ, *IL-2, TNF-α* level and inhibits tumor growth in vivo .

HY-P99048

Sintilimab IBI308	Classification of Application Fields Disease Research Fields Cancer	PD-1/PD-L1
Sintilimab (IBI308) is a safe and effectivel humanized IgG4 monoclonal antibody that binds to PD-1 with a K_D value of 74 pM. Sintilimab blocks the interaction of PD-1 with its ligands (PD-L1 and PL-L2), consequently helping to restore the endogenous antitumour T-cell response. Sintilimab combined with prebiotics inhibits tumor volume and regulates immune cell subpopulation balance in lung adenocarcinoma mice. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer ^[2] .

HY-N0694

Schisantherin A 1 Publications Verification Gomisin-C; Schizantherin-A; Wuweizi ester-A	Structural Classification Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill. Inflammation/Immunology Disease Research Fields	NF-κB
Schisantherin A is a dibenzocyclooctadiene lignan. Schisantherin A inhibits p65-NF-κB translocation into the nucleus by IκBα degradation.

HY-P99573

Tebotelimab MGD-013	Classification of Application Fields Disease Research Fields Cancer	LAG-3
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific PD-1/LAG-3 dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC₅₀s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity ^[2] .

HY-128736

L-2-Phosphoglyceric acid	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
L-2-Phosphoglyceric acid is an endogenous metabolite .

HY-128736C

L-2-Phosphoglyceric acid sodium hydrate	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
L-2-Phosphoglyceric acid sodium hydrate is an endogenous metabolite .

HY-N0692R

Schisandrol B (Standard)	Structural Classification Source classification Lignans Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill.	Reactive Oxygen Species Cytochrome P450 Autophagy
Schisandrol B (Standard) is the analytical standard of Schisandrol B. This product is intended for research and analytical applications. Schisandrol B (Gomisin-A) is a major active constituent of Schisandra chinensis with hepato-protective effects. Schisandrol B inhibits reactive oxygen species (ROS) production. Schisandrol B inhibits the activity of P-glycoprotein and CYP3A and also has anti-inflammatory, anti-diabetic and antioxidant activities ^[2] .

HY-N3834

*Epipterosin L 2'-O-glucoside*	Structural Classification Terpenoids Sesquiterpenes Source classification Cibotiaceae Plants Cibotium barometz (L.) J. Sm.	Others
Epipterosin L 2'-O-glucoside is a Sesquiterpenoids product that can be isolated from the rhizomes of Cibotium barometz (L.) J.Sm. .

HY-101414

L-DABA L-2,4-Diaminobutyric acid	Structural Classification Neurological Disease Classification of Application Fields Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Cancer	GABA Receptor Endogenous Metabolite
L-DABA (L-2,4-Diaminobutyric acid) is a week GABA transaminase inhibitor with an IC₅₀ of larger than 500 μM; exhibits antitumor activity in vivo and in vitro.

HY-113039

L-2-Hydroxyglutaric acid (S)-2-Hydroxyglutaric acid	Structural Classification Microorganisms Classification of Application Fields Anti-aging Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Cancer	Histone Demethylase Mitochondrial Metabolism Endogenous Metabolite
L-2-Hydroxyglutaric acid is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with K_m and K_i of 2.52 mM and 11.13 mM, respectively ^[2].

HY-W015114

L-2-Hydroxyglutaric acid disodium (S)-2-Hydroxyglutaric acid disodium	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Cancer	Histone Demethylase Mitochondrial Metabolism Endogenous Metabolite
L-2-Hydroxyglutaric acid disodium is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid disodium can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with K_m and K_i of 2.52 mM and 11.13 mM, respectively ^[2].

HY-101414A

L-DABA hydrobromide L-2,4-Diaminobutyric acid hydrobromide	Structural Classification Neurological Disease Classification of Application Fields Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Cancer	Endogenous Metabolite GABA Receptor
L-DABA (L-2,4-Diaminobutyric acid) hydrobromide is a week GABA transaminase inhibitor with an IC₅₀ of larger than 500 μM; exhibits antitumor activity in vivo and in vitro.

HY-113039R

L-2-Hydroxyglutaric acid (Standard) (S)-2-Hydroxyglutaric acid (Standard)	Structural Classification Microorganisms Ketones, Aldehydes, Acids Endogenous metabolite	Histone Demethylase Mitochondrial Metabolism Endogenous Metabolite
L-2-Hydroxyglutaric acid (Standard) is the analytical standard of L-2-Hydroxyglutaric acid. This product is intended for research and analytical applications. L-2-Hydroxyglutaric acid is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with K_m and K_i of 2.52 mM and 11.13 mM, respectively ^[2].

HY-W015114R

L-2-Hydroxyglutaric acid disodium (Standard) (S)-2-Hydroxyglutaric acid disodium (Standard)	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Histone Demethylase Mitochondrial Metabolism Endogenous Metabolite
L-2-Hydroxyglutaric acid (disodium) (Standard) is the analytical standard of L-2-Hydroxyglutaric acid (disodium). This product is intended for research and analytical applications. L-2-Hydroxyglutaric acid disodium is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid disodium can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with K_m and K_i of 2.52 mM and 11.13 mM, respectively ^[2].

HY-N12650

*Kaempferol 3-O-alpha-L-(2, 3-di-Z-p-coumaroyl) rhamnoside*	Structural Classification Flavonols Flavonoids Platanus occidentalis L. Source classification Phenols Polyphenols Platanaceae Plants	Endogenous Metabolite
Kaempferol 3-O-alpha-L-(2, 3-di-Z-p-coumaroyl) rhamnoside (compound 42) is a flavonol that can be isolated from Platanus Occidentalis. Kaempferol 3-O-alpha-L-(2, 3-di-Z-p-coumaroyl) rhamnoside is an inhibitor of alpha-amylase and DPP IV .

Species:	Human (36) Rhesus Macaque (3) Mouse (13) Rat (2) Cynomolgus (3)
Tag:	His (42) SUMO (2) Strep (2) Avi (4) Myc (1) GST (3) MBP (1) Fc (8) Flag (1)
Source:	HEK293 (32) E. coli Cell-free (2) P. pastoris (2) Sf9 insect cells (4) E. coli (14)

Cat. No.	Compare	Product Name	Species	Source

HY-P7755

	Cathepsin L2 Protein, Human (HEK293, His) rHuCathepsin L2, His; Cathepsin L2; Cathepsin U; Cathepsin V; CTSL2; CATL2; CTSU; CTSV	Human	HEK293
	Cathepsin L2 Protein, Human (HEK293, His) is a functional cysteine proteinase, mainly expressed in the cornea, testis, thymus, and epidermis.

HY-P7755A

	Cathepsin L2 Protein, Human (HEK293, His, solution) Cathepsin L2; Cathepsin U; Cathepsin V; CTSL2; CATL2; CTSU; CTSV	Human	HEK293
	Cathepsin L2 is a cysteine protease thought to play a crucial role in corneal physiology, but its specific function and mechanism are still under investigation. The unique properties of cathepsin L2 suggest that it may be involved in important cellular and molecular events within the cornea, underscoring its importance in maintaining ocular tissue health. Cathepsin L2 Protein, Human (HEK293, His, solution) is the recombinant human-derived Cathepsin L2 protein, expressed by HEK293 , with C-His labeled tag. The total length of Cathepsin L2 Protein, Human (HEK293, His, solution) is 317 a.a., with molecular weight of ~33-38 kDa.

HY-P77074

	MAB21L2 Protein, Human (His) Protein mab-21-like 2; MAB21L2	Human	E. coli
	MAB21L2 protein, encoded by the MAB21L2 gene, is similar to the C. elegans MAB-21 gene, involved in neural fate determination. It is primarily found in the nucleus and occasionally in the cytoplasm, potentially playing a role in neural development. MAB21L2 Protein, Human (His-ZZ) is the recombinant human-derived MAB21L2 protein, expressed by E. coli , with N-His labeled tag.

HY-P7399

	PD-L2 Protein, Human (HEK293, Fc) rHuPD-L2, Fc Chimera; Programmed cell death 1 ligand 2; B7DC; CD273	Human	HEK293
	PD-L2 Protein, Human (HEK293, Fc), a second ligand for PD-1, interacts with PD-1 negatively regulates T cell proliferation, cytokine production and cytotoxic activity.

HY-P71559

	NAALADL2 Protein, Human (His-SUMO) Glutamate carboxypeptidase II type non peptidase homologue; Inactive N acetylated alpha linked acidic dipeptidase like protein 2; Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2; N acetylated alpha linked acidic dipeptidase like 2; NAALADase L2; NAALADL 2; NAALADL2	Human	E. coli
	The NAALADL2 protein was identified as catalytically inactive, suggesting a role beyond enzymatic activity. The name implies that non-enzymatic functions contribute to different cellular processes. NAALADL2 Protein, Human (His-SUMO) is the recombinant human-derived NAALADL2 protein, expressed by E. coli , with N-His, N-SUMO labeled tag.

HY-P700539

	CXCR3 Protein, Human (Cell-Free, His) G protein coupled receptor 9 , GPR9; C-X-C chemokine receptor type 3; CD183; CKR L2; CMKAR3; IP10 R; MigR; CXC-R3; CXCR-3; Mig receptor; IP10 receptor; IP-10 receptor; G protein-coupled receptor 9; chemokine C-X-C receptor 3; interferon-inducible protein 10 receptor; GPR9; CD182; Mig-R; CKR-L2; IP10-R	Human	E. coli Cell-free
	The CXCR3 protein acts as a receptor for CXC chemokines (CXCL9, CXCL10, and CXCL11), affecting human mesangial cells (HMC) through G protein signaling. It binds CCL21 and may promote cell chemotaxis. CXCR3 Protein, Human (Cell-Free, His) is the recombinant human-derived CXCR3 protein, expressed by E. coli Cell-free , with C-10*His labeled tag.

HY-P78038

	SEZ6L2//BSRP-A Protein, Mouse (HEK293, His) BSRP-A; PSK-1; SEZ6L2; UNQ1903/PRO4349	Mouse	HEK293
	The SEZ6L2//BSRP-A protein is a contributor to specialized endoplasmic reticulum function in neurons, implying a unique role in coordinating specific cellular activities. Its identification demonstrates potential effects on the regulation and maintenance of neuronal function, emphasizing its importance in neuronal cellular processes. SEZ6L2//BSRP-A Protein, Mouse (HEK293, His) is the recombinant mouse-derived SEZ6L2//BSRP-A protein, expressed by HEK293 , with C-His labeled tag.

HY-P7816

	CHI3L2 Protein, Human (HEK293, His) rHuChitinase-3-like protein 2/CHI3L2, His; Chitinase-3-Like Protein 2; Chondrocyte Protein 39; YKL-39; CHI3L2	Human	HEK293
	CHI3L2, a lectin, exhibits high affinity for chitooligosaccharides and diverse glycans, except heparin. Importantly, CHI3L2 lacks chitinase activity, setting it apart from enzymes involved in chitin hydrolysis. CHI3L2 Protein, Human (HEK293, His) is the recombinant human-derived CHI3L2 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of CHI3L2 Protein, Human (HEK293, His) is 364 a.a., with molecular weight of ~40.0 kDa.

HY-P78505

	PD-L2 Protein, Human (HEK293, His-Avi) PDL2; PD-L2; Butyrophilin B7-DC; CD273, PDCD1 ligand 2; PDCD1L2; PDCD1LG2; B7DC; bA574F11.2; Btdc	Human	HEK293
	PD-L2 Protein, operating independently of PDCD1, plays a vital role in T-cell proliferation and IFNG production. Its interaction with PDCD1 inhibits proliferation and cytokine production. The interplay between PD-L2 and PDCD1 regulates immune responses, influencing T-cell activation and function. This molecular interaction adds complexity to mechanisms governing T-cell behavior, highlighting PD-L2's versatile role in immune regulation. PD-L2 Protein, Human (HEK293, His-Avi) is the recombinant human-derived PD-L2 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P703015

	SIRT2 Protein, Human (GST) SIR2L; SIR2L2	Human	E. coli
	SIRT2 Protein, Human (GST) is the recombinant human-derived SIRT2, expressed by E. coli , with GST labeled tag. ,

HY-P700894

	PD-L2 Protein, Cynomolgus/Rhesus macaque (HEK293, C-His) PDL2; PD-L2; Butyrophilin B7-DC; CD273, PDCD1 ligand 2; PDCD1L2; PDCD1LG2; B7DC; bA574F11.2; Btdc	Rhesus Macaque;Cynomolgus	HEK293
	PD-L2 Protein is an immune checkpoint receptor ligand that binds to PD-1 to activate pathways that inhibit TCR/ BCR-mediated immune cell activation. PDCD1LG2 can inhibit T-cell proliferation and inflammatory cytokine production. The expression of PDCD1LG2 on mouse tumor cells inhibits cytotoxic T-cell-mediated immune responses and can be used as a biomarker or prognostic indicator. PD-L2 Protein, Cynomolgus/Rhesus macaque (HEK293, C-His) is the recombinant cynomolgus-derived PD-L2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P700087AF

	Animal-Free HDGF Protein, Human (His) Hepatoma-Derived Growth Factor; HDGF; High Mobility Group Protein 1-Kike 2; HMG-1L2; HDGF; HMG1L2	Human	E. coli
	The HDGF protein acts as a transcriptional repressor and was previously thought to have mitogenic activity for fibroblasts and be a heparin-binding protein. However, recent studies have shown that it does not exhibit mitogenic activity for fibroblasts and does not bind heparin. Animal-Free HDGF Protein, Human (His) is the recombinant human-derived animal-FreeHDGF protein, expressed by E. coli , with C-His labeled tag.

HY-P700181AF

	Animal-Free HDGF Protein, Mouse (His) Hepatoma-Derived Growth Factor; HDGF; High Mobility Group Protein 1-Kike 2; HMG-1L2; HDGF; HMG1L2	Mouse	E. coli
	HDGF Protein, a transcriptional repressor, promotes fibroblast mitogenic activity. Existing as a monomer or domain-swapped homodimer, it interacts with nuclear proteins NCL and YBX1/YB1. Animal-Free HDGF Protein, Mouse (His) is the recombinant mouse-derived animal-FreeHDGF protein, expressed by E. coli , with C-His labeled tag. The total length of Animal-Free HDGF Protein, Mouse (His) is 237 a.a., with molecular weight of ~27.08 kDa.

HY-P73370

	PD-L2 Protein, Rat (HEK293, Fc) Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; B7-DC; CD273	Rat	HEK293
	Programmed cell death 1 ligand 2 (Pdcd1lg2, Pd-l2, B7-DC) is a member of B7 family and a ligand of programmed cell death 1. Pdcd1lg2 negatively regulates activated T cell proliferation, interferon-gamma production and interleukin-10 production in a PDCD1-independent manner, or inhibits T-cell proliferation by blocking cell cycle progression and cytokine production by interacts with PDCD1, and consequently causes cancer growth and suppresses the immune system. PD-L2 Protein, Rat (HEK293, Fc) is the recombinant rat-derived PD-L2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P73371

	PD-L2 Protein, Rat (HEK293, His) Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; B7-DC; CD273	Rat	HEK293
	Programmed cell death 1 ligand 2 (Pdcd1lg2, Pd-l2, B7-DC) is a member of B7 family and a ligand of programmed cell death 1. Pdcd1lg2 negatively regulates activated T cell proliferation, interferon-gamma production and interleukin-10 production in a PDCD1-independent manner, or inhibits T-cell proliferation by blocking cell cycle progression and cytokine production by interacts with PDCD1, and consequently causes cancer growth and suppresses the immune system. PD-L2 Protein, Rat (HEK293, His) is the recombinant rat-derived PD-L2 protein, expressed by HEK293 , with C-His labeled tag. The total length of PD-L2 Protein, Rat (HEK293, His) is 200 a.a., with molecular weight of ~35.7 kDa.

HY-P77528

	PD-L2 Protein, Human (Biotinylated, HEK293, His) Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; B7-DC; CD273	Human	HEK293
	PD-L2 Protein, operating independently of PDCD1, plays a vital role in T-cell proliferation and IFNG production. Its interaction with PDCD1 inhibits proliferation and cytokine production. The interplay between PD-L2 and PDCD1 regulates immune responses, influencing T-cell activation and function. This molecular interaction adds complexity to mechanisms governing T-cell behavior, highlighting PD-L2's versatile role in immune regulation. PD-L2 Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived PD-L2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P703910

	CD99L2 Protein, Mouse (His) CD99 molecule-like 2	Mouse	HEK293

HY-P70368

	HDGF Protein, Human (His) rHuHepatoma-derived growth factor/HDGF, His; Hepatoma-Derived Growth Factor; HDGF; High Mobility Group Protein 1-Kike 2; HMG-1L2; HDGF; HMG1L2	Human	E. coli
	The HDGF protein acts as a transcriptional repressor and was previously thought to have mitogenic activity for fibroblasts and be a heparin-binding protein. However, recent studies have shown that it does not exhibit mitogenic activity for fibroblasts and does not bind heparin. HDGF Protein, Human (His) is the recombinant human-derived HDGF protein, expressed by E. coli , with C-6*His labeled tag.

HY-P72697

	CD99L2 Protein, Human (HEK293, His) CD99 Antigen-Like Protein 2; MIC2-Like Protein 1; CD99; CD99L2; MIC2L1	Human	HEK293
	The CD99L2 protein plays a critical role in late leukocyte extravasation, helping cells to overcome the endothelial basement membrane. It acts independently at the same site as PECAM1, coordinating but uniquely participating in the complex process of leukocyte migration. CD99L2 Protein, Human (HEK293, His) is the recombinant human-derived CD99L2 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P76813

	CD99L2 Protein, Mouse (HEK293, Fc) CD99 Antigen-Like Protein 2; MIC2-Like Protein 1; CD99; CD99L2; MIC2L1	Mouse	HEK293
	CD99L2 Protein is crucial in aiding leukocytes during a late stage of extravasation by facilitating the overcoming of the endothelial basement membrane barrier. Independently acting at the same site as PECAM1, CD99L2 serves as a homophilic adhesion molecule, even though its interactions may not be essential for cell aggregation. CD99L2 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CD99L2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P76814

	CD99L2 Protein, Mouse (HEK293, His) CD99 Antigen-Like Protein 2; MIC2-Like Protein 1; CD99; CD99L2; MIC2L1	Mouse	HEK293
	CD99L2 Protein is crucial in aiding leukocytes during a late stage of extravasation by facilitating the overcoming of the endothelial basement membrane barrier. Independently acting at the same site as PECAM1, CD99L2 serves as a homophilic adhesion molecule, even though its interactions may not be essential for cell aggregation. CD99L2 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CD99L2 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD99L2 Protein, Mouse (HEK293, His) is 139 a.a., with molecular weight of 24-30 kDa.

HY-P73369

	PD-L2 Protein, Mouse (219a.a, HEK293, His) Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; B7-DC; CD273	Mouse	HEK293
	PD-L2 Protein plays a critical role in the T-cell costimulatory signal, fostering proliferation and IFNG production independently of PDCD1. While interacting with PDCD1 inhibits T-cell proliferation, PD-L2 itself intricately promotes immune responses. The dynamic interplay emphasizes PD-L2's dual role in either promoting or inhibiting T-cell activation within the immune signaling network, showcasing intricate regulatory mechanisms. PD-L2 Protein, Mouse (219a.a, HEK293, His) is the recombinant mouse-derived PD-L2 protein, expressed by HEK293 , with C-His labeled tag. The total length of PD-L2 Protein, Mouse (219a.a, HEK293, His) is 200 a.a., with molecular weight of 31-40 kDa.

HY-P700973

	CDH19 Protein, Human (Flag-MBP) Cadherin-19; Cadherin19; CDH7L2; cad19	Human	E. coli
	CDH19 Protein, a calcium-dependent cell adhesion protein, engages in homophilic interactions, primarily connecting cells. This adhesive property suggests a potential role for cadherins, including CDH19, in facilitating the sorting of diverse cell types. CDH19 Protein, Human (Flag-MBP) is the recombinant human-derived CDH19 protein, expressed by E. coli , with N-MBP, N-Flag labeled tag. The total length of CDH19 Protein, Human (Flag-MBP) is 526 a.a., with molecular weight of 100.89 kDa.

HY-P702906

	SIRT2 Protein, Human (His) SIR2L; SIR2L2; Sirtuin 2	Human	E. coli
	SIRT2 Protein, Human (His) is the recombinant human-derived SIRT2, expressed by E. coli , with C-6*His labeled tag. ,

HY-P70839

	MORF4L2 Protein, Human (His) Mortality Factor 4-Like Protein 2; MORF-Related Gene X Protein; Protein MSL3-2; Transcription Factor-Like Protein MRGX; MORF4L2; KIAA0026; MRGX	Human	E. coli
	The MORF4L2 protein is an important component of the NuA4 histone acetyltransferase complex and promotes transcriptional activation by acetylating histones H4 and H2A. This modification alters nucleosome-DNA interactions and promotes interactions with other transcription-positive proteins. MORF4L2 Protein, Human (His) is the recombinant human-derived MORF4L2 protein, expressed by E. coli , with C-6*His labeled tag. The total length of MORF4L2 Protein, Human (His) is 288 a.a., with molecular weight of 33-36 kDa.

HY-P70734

	PD-L2 Protein, Human (HEK293, mFc) Programmed Cell Death 1 Ligand 2; PD-1 Ligand 2; PD-L2; PDCD1 Ligand 2; Programmed Death Ligand 2; Butyrophilin B7-DC; B7-DC; CD273; PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2	Human	HEK293
	PD-L2 Protein, operating independently of PDCD1, plays a vital role in T-cell proliferation and IFNG production. Its interaction with PDCD1 inhibits proliferation and cytokine production. The interplay between PD-L2 and PDCD1 regulates immune responses, influencing T-cell activation and function. This molecular interaction adds complexity to mechanisms governing T-cell behavior, highlighting PD-L2's versatile role in immune regulation. PD-L2 Protein, Human (HEK293, mFc) is the recombinant human-derived PD-L2 protein, expressed by HEK293 , with C-mFc labeled tag.

HY-P700488

	HDGF Protein, Mouse (P. pastoris, N-His, C-Myc) rHuHepatoma-derived growth factor/HDGF, His; Hepatoma-Derived Growth Factor; HDGF; High Mobility Group Protein 1-Kike 2; HMG-1L2; HDGF; HMG1L2	Mouse	P. pastoris
	HDGF Protein, a transcriptional repressor, promotes fibroblast mitogenic activity. Existing as a monomer or domain-swapped homodimer, it interacts with nuclear proteins NCL and YBX1/YB1. HDGF Protein, Mouse (P. pastoris, N-His, C-Myc) is the recombinant mouse-derived HDGF protein, expressed by P. pastoris, with C-Myc, N-10*His labeled tag. The total length of HDGF Protein, Mouse (P. pastoris, N-His, C-Myc) is 237 a.a., with molecular weight of 30.3 kDa.

HY-P77731

	Kallikrein-5 Protein, Mouse (HEK293, His) Kallikrein c; Klnc; KLK5; KLKL2; KLK-L2; SCTE	Mouse	HEK293
	The Kallikrein-5 protein may be involved in desquamation, suggesting a role in the process of skin shedding and exfoliation. Its association with desquamation suggests that it plays a role in regulating the removal of dead skin cells, which is critical for skin homeostasis. Kallikrein-5 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Kallikrein-5 protein, expressed by HEK293 , with C-His labeled tag. The total length of Kallikrein-5 Protein, Mouse (HEK293, His) is 264 a.a., with molecular weight of 40-50 kDa.

HY-P70964

	PD-L2 Protein, Rhesus macaque/Cynomolgus (HEK293, Fc) Programmed Cell Death 1 Ligand 2; PD-1 Ligand 2; PD-L2; PDCD1 Ligand 2; Programmed Death Ligand 2; Butyrophilin B7-DC; B7-DC; CD273; PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2	Rhesus Macaque;Cynomolgus	HEK293
	PDCD1LG2 is an immune checkpoint receptor ligand that binds to PD-1 to activate pathways that inhibit TCR/ BCR-mediated immune cell activation. PDCD1LG2 can inhibit T-cell proliferation and inflammatory cytokine production. The expression of PDCD1LG2 on mouse tumor cells inhibits cytotoxic T-cell-mediated immune responses and can be used as a biomarker or prognostic indicator. PD-L2 Protein, Rhesus macaque/Cynomolgus (HEK293, Fc) is the recombinant cynomolgus-derived PD-L2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P702920

	CDK11A-CCND3 Protein, Human (sf9, GST) CDC2L2; CDC2L3; PITSLREB	Human	Sf9 insect cells
	CDK11A-CCND3 Protein, Human (sf9, GST) is the recombinant human-derived CDK11A-CCND3, expressed by Sf9 insect cells , with N-GST labeled tag. ,

HY-P72407

	PD-L2 Protein, Human (Biotinylated, HEK293, His-Avi) PD-1 Ligand 2; PDCD1 Ligand 2; B7-DC; CD273; PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2	Human	HEK293
	PD-L2 Protein, operating independently of PDCD1, plays a vital role in T-cell proliferation and IFNG production. Its interaction with PDCD1 inhibits proliferation and cytokine production. The interplay between PD-L2 and PDCD1 regulates immune responses, influencing T-cell activation and function. This molecular interaction adds complexity to mechanisms governing T-cell behavior, highlighting PD-L2's versatile role in immune regulation. PD-L2 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived PD-L2 protein, expressed by HEK293 , with C-Avi, C-6*His labeled tag.

HY-P72492

	PD-L2 Protein, Human (HEK293, His) Programmed cell death 1 ligand 2; Pdcd1lg2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273	Human	HEK293
	PD-L2 Protein, operating independently of PDCD1, plays a vital role in T-cell proliferation and IFNG production. Its interaction with PDCD1 inhibits proliferation and cytokine production. The interplay between PD-L2 and PDCD1 regulates immune responses, influencing T-cell activation and function. This molecular interaction adds complexity to mechanisms governing T-cell behavior, highlighting PD-L2's versatile role in immune regulation. PD-L2 Protein, Human (HEK293, His) is the recombinant human-derived PD-L2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P77200

	SEZ6L2//BSRP-A Protein, Human (HEK293, His) Seizure 6-like protein 2; PSK; BSRPA	Human	HEK293
	SEZ6L2/BSRP-A, potentially contributing to specialized functions in the endoplasmic reticulum (ER) of neurons, hints at a role critical for neuronal homeostasis.Its significance in the intricate molecular processes essential for neuronal function underscores the need for further exploration to unveil specific mechanisms and pathways through which SEZ6L2/BSRP-A participates in specialized ER functions.SEZ6L2//BSRP-A Protein, Human (HEK293, His) is the recombinant human-derived SEZ6L2//BSRP-A protein, expressed by HEK293 , with C-His labeled tag.

HY-P703560

	DCAF2-DDB1 Protein, Human (Sf9, His, Strep) CDT2; CDW1; DCAF2; L2DTL; RAMP	Human	Sf9 insect cells

HY-P72491

	PD-L2 Protein, Mouse (200a.a, HEK293, Fc) Programmed cell death 1 ligand 2; Pdcd1lg2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273	Mouse	HEK293
	PD-L2 Protein plays a critical role in the T-cell costimulatory signal, fostering proliferation and IFNG production independently of PDCD1. While interacting with PDCD1 inhibits T-cell proliferation, PD-L2 itself intricately promotes immune responses. The dynamic interplay emphasizes PD-L2's dual role in either promoting or inhibiting T-cell activation within the immune signaling network, showcasing intricate regulatory mechanisms. PD-L2 Protein, Mouse (200a.a, HEK293, Fc) is the recombinant mouse-derived PD-L2 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of PD-L2 Protein, Mouse (200a.a, HEK293, Fc) is 200 a.a., with molecular weight of 70-80 kDa.

HY-P72493

	PD-L2 Protein, Rhesus macaque/Cynomolgus (HEK293, His) Programmed cell death 1 ligand 2; Pdcd1lg2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273	Rhesus Macaque;Cynomolgus	HEK293
	PDCD1LG2 is an immune checkpoint receptor ligand that binds to PD-1 to activate pathways that inhibit TCR/ BCR-mediated immune cell activation. PDCD1LG2 can inhibit T-cell proliferation and inflammatory cytokine production. The expression of PDCD1LG2 on mouse tumor cells inhibits cytotoxic T-cell-mediated immune responses and can be used as a biomarker or prognostic indicator. PD-L2 Protein, Rhesus macaque/Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived PD-L2 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P703057

	CDK11A Protein, Human (sf9, GST) CDC2L2; CDC2L3; PITSLREB; Cyclin-dependent kinase 11A	Human	Sf9 insect cells
	CDK11A Protein, Human (sf9, GST) is the recombinant human-derived CDK11A, expressed by Sf9 insect cells , with GST labeled tag. The total length of CDK11A Protein, Human (sf9, GST) is 423 a.a.,

HY-P701353

	UBE1L2/UBA6 Protein, Human (Sf9, His, Strep) UBA6; Ubiquitin-like modifier-activating enzyme 6; Ubiquitin-activating enzyme 6; Monocyte protein 4; MOP-4; Ubiquitin-activating enzyme E1-like protein 2; E1-L2	Human	Sf9 insect cells
	The ubiquitin E1 enzyme initiates ubiquitination by adenylating ubiquitin with ATP and forming a thioester bond with the E1 enzyme. It exhibits specificity for ubiquitin and excludes ubiquitin-like peptides. UBE1L2/UBA6 Protein, Human (Sf9, His, Strep) is the recombinant human-derived UBE1L2/UBA6 protein, expressed by Sf9 insect cells , with N-Strep, N-8*His labeled tag. The total length of UBE1L2/UBA6 Protein, Human (Sf9, His, Strep) is 1051 a.a., .

HY-P76866

	DCUN1D2 Protein, Human (His) DCN1-like protein 2; DCNL2; C13orf17; DCUN1L2	Human	E. coli
	The DCUN1D2 protein transfers NEDD8 from NEDD8-conjugated E2 to the cullin-RBX complex and regulates SCF-type complex activity. DCUN1D2 Protein, Human (His) is the recombinant human-derived DCUN1D2 protein, expressed by E. coli , with N-His labeled tag.

HY-P702844

	NF2L2 Protein, Mouse (His) NF-E2-related factor 2; NFE2-related factor 2; Nrf2	Mouse	E. coli

HY-P70939

	Kallikrein-5 Protein, Human (HEK293, His) Kallikrein-5; Kallikrein-Like Protein 2; KLK-L2; Stratum Corneum Tryptic Enzyme; KLK5; SCTE	Human	HEK293
	The Kallikrein-5 protein may be involved in desquamation, suggesting a role in the process of skin shedding and exfoliation.Its association with desquamation suggests that it plays a role in regulating the removal of dead skin cells, which is critical for skin homeostasis.Kallikrein-5 Protein, Human (HEK293, His) is the recombinant human-derived Kallikrein-5 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70939A

	Kallikrein-5 Protein, Human (HEK293, C-His) Kallikrein-5; Kallikrein-Like Protein 2; KLK-L2; Stratum Corneum Tryptic Enzyme; KLK5; SCTE	Human	HEK293
	The Kallikrein-5 protein may be involved in desquamation, suggesting a role in the process of skin shedding and exfoliation. Its association with desquamation suggests that it plays a role in regulating the removal of dead skin cells, which is critical for skin homeostasis. Kallikrein-5 Protein, Human (HEK293,C-His) is the recombinant human-derived Kallikrein-5 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P76678

	TMED9 Protein, Human (HEK293, His) Transmembrane emp24 domain-containing protein 9; GMP25; p24alpha2; p25; GP25L2	Human	HEK293
	TMED9, a key player in vesicular protein trafficking, operates prominently in the early secretory pathway, specifically in COPI vesicle-mediated retrograde transport. It facilitates coatomer recruitment to membranes, enhances ARFGAP2 activity, and ensures specific retention of p24 complexes in cis-Golgi membranes, notably influencing TMED2 and TMED10 localization. Beyond retrograde transport, TMED9 contributes to intracellular membrane organization, including the ER-Golgi intermediate compartment and Golgi apparatus, and participates in PTPN2 isoform PTPB ER localization. TMED9's dynamic oligomeric states involve monomers and homodimers, influenced by its interactions with EMP24/GP25L family members (TMED2, TMED7, and TMED10) and specific associations with TMED5, COPG1, PTPN2, SPAST, and STX17. TMED9 Protein, Human (HEK293, His) is the recombinant human-derived TMED9 protein, expressed by HEK293, with C-His labeled tag. The total length of TMED9 Protein, Human (HEK293, His) is 165 a.a., with molecular weight of ~20.8 kDa.

HY-P76679

	TMED9 Protein, Human (HEK293, Fc) Transmembrane emp24 domain-containing protein 9; GMP25; p24alpha2; p25; GP25L2	Human	HEK293
	TMED9, a key player in vesicular protein trafficking, operates prominently in the early secretory pathway, specifically in COPI vesicle-mediated retrograde transport. It facilitates coatomer recruitment to membranes, enhances ARFGAP2 activity, and ensures specific retention of p24 complexes in cis-Golgi membranes, notably influencing TMED2 and TMED10 localization. Beyond retrograde transport, TMED9 contributes to intracellular membrane organization, including the ER-Golgi intermediate compartment and Golgi apparatus, and participates in PTPN2 isoform PTPB ER localization. TMED9's dynamic oligomeric states involve monomers and homodimers, influenced by its interactions with EMP24/GP25L family members (TMED2, TMED7, and TMED10) and specific associations with TMED5, COPG1, PTPN2, SPAST, and STX17. TMED9 Protein, Human (HEK293, Fc) is the recombinant human-derived TMED9 protein, expressed by HEK293, with C-mFc labeled tag. The total length of TMED9 Protein, Human (HEK293, Fc) is 202 a.a., with molecular weight of ~45.8 kDa.

HY-P702333

	IFI27L2A Protein, Mouse (Cell-Free, His) Interferon alpha-inducible protein 27-like protein 2A; Interferon-stimulated gene 12 protein; ISG12	Mouse	E. coli Cell-free
	The IFI27L2A protein critically regulates interferon-induced transcriptional activity, specifically NR4A1, NR4A2, and NR4A3. Its interaction with XPO1 enhances the nuclear export of these receptors, with potential vascular effects on the injury response. IFI27L2A Protein, Mouse (Cell-Free, His) is the recombinant mouse-derived IFI27L2A protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of IFI27L2A Protein, Mouse (Cell-Free, His) is 66 a.a., with molecular weight of 7.3 kDa.

HY-P78354

	Siglec-5 Protein, Mouse (HEK293, His) CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2	Mouse	HEK293
	Siglec-F Protein, a putative adhesion molecule, crucially mediates sialic-acid dependent binding to cells with a preferential affinity for alpha-2,3-linked sialic acid. Notably, its sialic acid recognition site may be concealed through cis interactions with sialic acids on the same cell surface. Siglec-5 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Siglec-5 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-5 Protein, Mouse (HEK293, His) is 423 a.a., with molecular weight of 65-68 kDa.

HY-P78203

	Siglec-5 Protein, Human (Biotinylated, HEK293, Fc) CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2	Human	HEK293
	Siglec-5 Protein, a putative adhesion molecule, participates in sialic-acid dependent cellular binding, showing equal affinity for alpha-2,3-linked and alpha-2,6-linked sialic acid. Its sialic acid recognition site may be masked through cis interactions with sialic acids on the same cell surface. Siglec-5 Protein, Human (Biotinylated, HEK293, Fc) is the recombinant human-derived Siglec-5 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Siglec-5 Protein, Human (Biotinylated, HEK293, Fc) is 418 a.a., with molecular weight of 90-115 kDa.

HY-P701038

	Siglec-5 Protein, Human (HEK293, His-Avi) CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2	Human	HEK293
	Siglec-5 Protein, a putative adhesion molecule, participates in sialic-acid dependent cellular binding, showing equal affinity for alpha-2,3-linked and alpha-2,6-linked sialic acid. Its sialic acid recognition site may be masked through cis interactions with sialic acids on the same cell surface. Siglec-5 Protein, Human (HEK293, His-Avi) is the recombinant human-derived Siglec-5 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of Siglec-5 Protein, Human (HEK293, His-Avi) is 418 a.a., with molecular weight of 68-78 kDa.

HY-P701039

	Siglec-5 Protein, Human (Biotinylated, HEK293, His-Avi) CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2	Human	HEK293
	Siglec-5 Protein, a putative adhesion molecule, participates in sialic-acid dependent cellular binding, showing equal affinity for alpha-2,3-linked and alpha-2,6-linked sialic acid. Its sialic acid recognition site may be masked through cis interactions with sialic acids on the same cell surface. Siglec-5 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived Siglec-5 protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of Siglec-5 Protein, Human (Biotinylated, HEK293, His-Avi) is 418 a.a., with molecular weight of 70-80 kDa.

HY-P7653

	Bcl-2-like protein 2 Protein, Human (His) rHuBcl-2-like protein 2, His; Bcl-2-Like Protein 2; Apoptosis Regulator Bcl-W; BCL2L2; KIAA0271	Human	E. coli
	Bcl-2-like protein 2 is a key regulator that promotes cell survival and prevents dexamethasone-induced apoptosis, which is critical for postmitotic Sertoli cells. It inhibits BAX, emphasizing its role in survival mechanisms. Bcl-2-like protein 2 Protein, Human (His) is the recombinant human-derived Bcl-2-like protein 2 protein, expressed by E. coli , with C-6*His labeled tag. The total length of Bcl-2-like protein 2 Protein, Human (His) is 171 a.a., with molecular weight of ~18.0 kDa.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-N0229S2

L-Alanine-15N
L-Alanine- ¹⁵N is the ¹⁵N-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system[1].

HY-N0229S12

L-Alanine-d3
L-Alanine-d₃ is the deuterium labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S13

L-Alanine-d7
L-Alanine-d₇ is the deuterium labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S3

L-Alanine-d4
L-Alanine-d₄ is the deuterium labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S1

L-Alanine-1-13C
L-Alanine-1- ¹³C is the ¹³C-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S9

L-Alanine-13C2
L-Alanine- ¹³C₂ is the ¹³C-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S6

L-Alanine-3-13C
L-Alanine-3- ¹³C is the ¹³C-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S7

L-Alanine-2-13C
L-Alanine-2- ¹³C is the ¹³C-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S8

L-Alanine-13C3
L-Alanine- ¹³C₃ is the ¹³C-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S14

L-Alanine-15N,d4
L-Alanine- ¹⁵N,d₄ is the deuterium and ¹⁵N-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S4

L-Alanine-13C,d1
L-Alanine- ¹³C,d is the ¹³C- and deuterium labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S

L-Alanine-2-13C,15N
L-Alanine-2- ¹³C, ¹⁵Nis the ¹³C-labeled and ¹⁵N-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S11

L-Alanine-1-13C,15N
L-Alanine-1- ¹³C, ¹⁵N is the ¹³C- and ¹⁵N-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S10

L-Alanine-13C3,15N
L-Alanine- ¹³C₃, ¹⁵N is the ¹³C- and ¹⁵N-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S15

L-Alanine-13C2,15N
L-Alanine- ¹³C₂, ¹⁵N is the ¹³C- and ¹⁵N-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

HY-N0229S5

L-Alanine-13C3,15N,d4
L-Alanine- ¹³C₃, ¹⁵N,d₄ is the deuterium, ¹³C-, and 15-labeled L-Alanine. L-Alanine is a non-essential amino acid, involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and central nervous system.

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81861

	LOXL2 Antibody (YA1606) LOR2; LOX L2; LOXL2; Lysyl oxidase homolog 2; Lysyl oxidase like 2; WS9 14	WB, ICC/IF, FC	Human, Mouse, Rat
	LOXL2 Antibody (YA1606) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1606), targeting LOXL2, with a predicted molecular weight of 87 kDa. LOXL2 Antibody (YA1606) can be used for WB, ICC/IF, FC experiment in human, mouse, rat background.

HY-P80520

	TCF7L2/TCF4 Antibody	WB, ICC/IF, IHC-P, IP, FC	Human, Mouse
	TCF7L2/TCF4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to TCF7L2/TCF4. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

HY-P81188

	CXCR3 Antibody CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC Motif Receptor 3; Chemokine CXC Motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.	WB	Human, Mouse, Rat
	CXCR3 Antibody is an unconjugated, approximately 40 kDa, rabbit-derived, anti-CXCR3 polyclonal antibody. CXCR3 Antibody can be used for: WB expriments in human, mouse, rat, and predicted: dog, pig, cow, rabbit, guinea pig background without labeling.

HY-P83692

	CXCR3 Antibody (YA3426) CXCR3_HUMAN; Interferon-inducible protein 10 receptor; IP-10 receptor; C-X-C chemokine receptor type 3; CD 183; CD183; CD183 antigen; G protein-coupled receptor 9; G Protein Coupled Receptor 9; Chemokine (C X C motif) receptor 3; Chemokine (C X C) receptor 3; C-X-C Chemokine receptor; CXC Motif Receptor 3; Chemokine CXC Motif Receptor 3; CKRL2; CKR L2; CKR-L2; GPR9; CXC-R3; CXCR-3; IP10 receptor.	WB, ICC/IF, IP	Human
	CXCR3 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-CXCR3 monoclonal antibody. CXCR3 Antibody can be used for: WB expriments in human background without labeling.

HY-P81839

	PD-L2 Antibody (YA1584) PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273	WB	Human, Rat
	PD L2 Antibody (YA1584) is a biotin-conjugated non-conjugated IgG antibody, targeting PD L2, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). PD L2 Antibody (YA1584) can be used for WB experiment in human, rat background.

HY-P83144

	Kallikrein 5 Antibody (YA2889) HK5; Kallikrein 5; Kallikrein L2; KLK 5; KLK L2; SCTE	WB, ICC/IF, FC	Human, Mouse
	Kallikrein 5 Antibody (YA2889) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2889), targeting Kallikrein 5, with a predicted molecular weight of 32 kDa (observed band size: 37 kDa). Kallikrein 5 Antibody (YA2889) can be used for WB, ICC/IF, FC experiment in human, mouse background.

HY-P81839A

	PD-L2 Antibody (YA3391) PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273; PD L2; PDL2	WB, ICC/IF, FC, ELISA	Human, Mouse, Rat

HY-P81603

	PD-L2 Antibody (YA1348) PD-1 ligand 2; PD-L2; PDCD1 ligand 2; B7-DC; CD273	FC, ELISA	Human
	PDL2 Antibody (YA1348) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1348), targeting PDL2. PDL2 Antibody (YA1348) can be used for FC, ELISA experiment in human background.

HY-P82729

	CDT2 Antibody (YA2474) CDW1; DCAF2; Dtl; L2DTL; RAMP	WB, IHC-P	Human
	CDT2 Antibody (YA2474) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2474), targeting CDT2, with a predicted molecular weight of 79 kDa (observed band size: 79 kDa). CDT2 Antibody (YA2474) can be used for WB, IHC-P experiment in human background.

HY-P83445

	MAD2L2 Antibody (YA3190) REV7; FANCV; MAD2B; POLZ2	WB, ICC/IF, IP	Human
	MAD2L2 Antibody (YA3190) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3190), targeting MAD2L2, with a predicted molecular weight of 24 kDa (observed band size: 24 kDa). MAD2L2 Antibody (YA3190) can be used for WB, ICC/IF, IP experiment in human background.

HY-P83155

	KAT2A Antibody (YA2900) GCN5; hGCN5; GCN5L2; PCAF-b	WB, IP	Human
	KAT2A Antibody (YA2900) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2900), targeting KAT2A, with a predicted molecular weight of 94 kDa (observed band size: 94 kDa). KAT2A Antibody (YA2900) can be used for WB, IP experiment in human background.

HY-P83413

	CDC45 Antibody (YA3158) CDC45L; CDC45L2; PORC-PI-1; CDC45	WB, IHC-P, ICC/IF, FC	Human, Mouse, Rat
	CDC45 Antibody (YA3158) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3158), targeting CDC45, with a predicted molecular weight of 66 kDa (observed band size: 66 kDa). CDC45 Antibody (YA3158) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.

HY-P81978

	ASH2L Antibody (YA1723) ASH2; Bre2; ASH2L1; ASH2L2	WB, ICC/IF, IP	Human, Rat
	ASH2L Antibody (YA1723) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1723), targeting ASH2L, with a predicted molecular weight of 69 kDa (observed band size: 80 kDa). ASH2L Antibody (YA1723) can be used for WB, ICC/IF, IP experiment in human, rat background.

HY-P82948

	AK3L1 Antibody (YA2693) AK3; AK 4; AK3L1; AK3L2	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	AK3L1 Antibody (YA2693) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2693), targeting AK3L1, with a predicted molecular weight of 25 kDa (observed band size: 25 kDa). AK3L1 Antibody (YA2693) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.

HY-P83615

	mtTFA Antibody (YA3360) MtTF1; mtTFA; TCF6; TCF6L1; TCF6L2; TCF6L3; TFAM; Transcription factor 6	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	mtTFA Antibody (YA3360) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3360), targeting mtTFA, with a predicted molecular weight of 29 kDa (observed band size: 24 kDa). mtTFA Antibody (YA3360) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.

HY-P82822

	Lysosome Membrane Protein 2 Antibody (YA2567) AMRF; CD36; CD36L2; EPM4; HLGP85; LGP85; LIMP2; LIMPII; Scarb2; SRBII	WB, IHC-P, IP, FC	Human, Mouse, Rat
	Lysosome Membrane Protein 2 Antibody (YA2567) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2567), targeting Lysosome Membrane Protein 2, with a predicted molecular weight of 54 kDa (observed band size: 77 kDa). Lysosome Membrane Protein 2 Antibody (YA2567) can be used for WB, IHC-P, IP, FC experiment in human, mouse, rat background.

HY-P83496

	SMARCA2 Antibody (YA3241) SMARCA2; BAF190B; BRM; SNF2A; SNF2L2; Probable global transcription activator SNF2L2; ATP-dependent helicase SMARCA2; BRG1-associated factor 190B; BAF190B; Protein brahma homolog; hBRM; SNF2-alpha; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2	WB, IHC-F, IHC-P, ICC/IF	Human
	SMARCA2 Antibody (YA3241) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3241), targeting SMARCA2, with a predicted molecular weight of 181 kDa (observed band size: 190 kDa). SMARCA2 Antibody (YA3241) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.

HY-P81051

	Nrf2 Antibody(YA895) NFE2L2; NRF2; Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor; erythroid derived 2; like 2	WB, IHC-P, ICC/IF, IP, ChIP	Human, Mouse
	Nrf2 Antibody(YA895) is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Nrf2(YA895) monoclonal antibody. Nrf2 Antibody(YA895) can be used for: WB, IHC-P, ICC/IF, IP, ChIP expriments in human, mouse background without labeling.

HY-P82422

	Transcription Factor 7 Like 2 Antibody (YA2167) TCF7L2; HMG box transcription factor 4; HTCF-4; T-cell factor-4 variant X2; T-cell factor 4; Transcription factor 7-like 2; TCF-4	WB, IHC-P, IP	Human
	Transcription Factor 7 Like 2 Antibody (YA2167) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2167), targeting Transcription Factor 7 Like 2, with a predicted molecular weight of 68 kDa (observed band size: 68 kDa). Transcription Factor 7 Like 2 Antibody (YA2167) can be used for WB, IHC-P, IP experiment in human background.

HY-P80471

	Phospho-Nrf2 (Ser40) Antibody (YA168) NFE2L2; NRF2; Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor; erythroid derived 2; like 2	WB, ICC/IF, IHC-P, FC, IP	Human
	Phospho-Nrf2 (Ser40) Antibody (YA168) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-Nrf2(S40). It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

HY-P80841

	Phospho-Nrf2 (Ser40) Antibody (YA169) NFE2L2; NRF2; Nuclear factor erythroid 2-related factor 2; NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor; erythroid derived 2; like 2	WB, IHC-P	Human
	Phospho-Nrf2 (Ser40) Antibody (YA169) is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to Phospho-Nrf2 (Ser40). It can be used for WB,IHC-P assays with tag free, in the background of Human.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Gomisin L-2

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Natural
Products